Excimer laser technology in percutaneous coronary interventions: Cardiovascular laser society's position paper

Int J Cardiol. 2022 Mar 1;350:19-26. doi: 10.1016/j.ijcard.2021.12.054. Epub 2022 Jan 5.


Excimer Laser Coronary Atherectomy (ELCA) is a well-established therapy that emerged for the treatment of peripheral vascular atherosclerosis in the late 1980s, at a time when catheters and materials were rudimentary and associated with the most serious complications. Refinements in catheter technology and the introduction of improved laser techniques have led to their effective use for the treatment of a wide spectrum of complex coronary lesions, such as thrombotic lesions, severe calcific lesions, non-crossable or non-expandable lesions, chronic occlusions, and stent under-expansion. The gradual introduction of high-energy strategies combined with the contrast infusion technique has enabled us to treat an increasing number of complex cases with a low rate of periprocedural complications. Currently, the use of the ELCA has also been demonstrated to be effective in acute coronary syndrome (ACS), especially in the context of large thrombotic lesions.

Keywords: Chronic occlusions; ELCA; Laser angioplasty; Severe calcific lesions; Stent under-expansion; Thrombotic lesions.

MeSH terms

  • Atherectomy, Coronary* / methods
  • Coronary Angiography
  • Humans
  • Lasers, Excimer / therapeutic use
  • Percutaneous Coronary Intervention* / methods
  • Technology
  • Treatment Outcome